Bharat Immunological & Biologicals Corporation Ltd.
|
Cash Flow
|
|
You can view the
Cash Flow
for the last 5 years.
Market Cap. (Rs.)
|
130.45 Cr.
|
P/BV
|
1.49
|
Book Value (Rs.)
|
20.33
|
52 Week High/Low (Rs.)
|
44/21
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
Bookclosure
|
29/12/2023
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
Net Profit/Loss Before Extraordinary Items And Tax | -22.85 | -9.69 | -14.20 | -14.20 | -7.37 |
| | | | | |
Net CashFlow From Operating Activities | 10.89 | -42.12 | 34.08 | 34.08 | -32.20 |
Net Cash Used In Investing Activities | 0.46 | 0.53 | 0.91 | 0.91 | 0.70 |
Net Cash Used From Financing Activities | -14.71 | 45.00 | -34.41 | -34.41 | 30.71 |
| | | | | |
Net Inc/Dec In Cash And Cash Equivalents | -3.36 | 3.42 | 0.58 | 0.58 | -0.79 |
Cash And Cash Equivalents Begin of Year | 4.64 | 1.23 | 0.41 | 0.41 | 1.20 |
Cash And Cash Equivalents End Of Year | 1.29 | 4.64 | 0.99 | 0.99 | 0.41 |